- Joined
- Aug 9, 2006
- Messages
- 1,073
- Reaction score
- 1,257
- Points
- 175
Convenience as the primary oncologic endpoint (which is almost every trial run in the last 10 years) has gotten entirely out of hand. One of these days (if we survive as a field) we'll get back to actually trying to improve REAL oncologic outcomes.
1) not every trial or almost every trial, gross exaggeration
2) I agree convenience on its own may not excite anyone at this point. However - I have to ask. If we had not made advances, radiation would still be 6 weeks for breast and 9 weeks for prostate. This puts our modality at a significant disadvantage for patients who are either comparing local options (prostate cancer) or considering whether they should get RT at all (breast cancer/DCIS).
5 fraction partial breast RT has been a BOON to my practice. As has 20-28 fraction prostate, and yes even SBRT sometimes (some patients choose SBRT over prostatectomy in my practice when given all options. Your mileage may vary but my patients like coming fewer times and it makes radiation more attractive. When they come to me after googling and thinking 9 weeks and hear about much shorter options, it is pretty apparent that their calculus has shifted).
We should not be so short sighted.